semaglutide ema approval Semaglutide: First Global | Drugs Novo Nordisk secures EMA approval

A new study analyzing over 215,000 GLP-1 users reveals patterns that extend far beyond weight metrics

Phase 3 trials of retatrutide are ongoing

published in the Federation of European Biochemical Societies Letters (a division of Wiley) and Hansen & Degushi , Acta veterinaria Scandinavica concluded that a glutathione deficiency can lead to instability of the sperms midpiece (which contains the mitochondria and ATP necessary for swimming) resulting in defective motility

Asia-Pacific is the fastest-growing region, supported by expanding access, rising obesity burden, and increased investments in metabolic disease treatment infrastructure